Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -19.66%47.91M | -30.52%51.5M | 11.51%59.44M | 12.55%247.63M | 9.98%60.57M | 8.57%59.63M | 27.76%74.13M | 2.53%53.3M | 0.03%220.01M | -6.60%55.07M |
| Cost of revenue | 19.66%109.71M | 10.08%91.69M | ||||||||
| Gross profit | 7.48%137.92M | -6.09%128.32M | ||||||||
| Operating expense | -8.04%54.58M | -21.68%54.42M | 8.51%61.83M | -2.00%140.62M | 3.34%61.15M | 3.05%59.35M | 15.83%69.49M | 5.57%56.98M | 2.36%143.49M | 415.15%59.17M |
| Selling and administrative expenses | ---- | ---- | ---- | -2.00%140.62M | ---- | ---- | ---- | ---- | 2.36%143.49M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -3.65%46.3M | ---- | ---- | ---- | ---- | 10.73%48.05M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -1.17%94.32M | ---- | ---- | ---- | ---- | -1.39%95.43M | ---- |
| Depreciation and amortization | 8.05%4.11M | 2.72%3.92M | -4.73%3.66M | -3.97%15.18M | -8.70%3.71M | -3.48%3.8M | -1.67%3.82M | -1.84%3.85M | --15.81M | --4.07M |
| -Depreciation | 8.05%4.11M | 2.72%3.92M | -4.73%3.66M | -3.97%15.18M | -8.70%3.71M | -3.48%3.8M | -1.67%3.82M | -1.84%3.85M | --15.81M | --4.07M |
| Other operating expenses | -8.77%51.04M | -23.42%50.88M | 8.94%58.56M | 7.36%234.88M | 3.94%58.66M | 2.79%55.95M | 16.66%66.44M | 4.89%53.75M | --218.78M | --56.43M |
| Total other operating income | 42.57%566K | -50.91%379K | -36.92%393K | -19.90%3.1M | -8.26%1.22M | -48.51%397K | -9.18%772K | -47.91%623K | --3.86M | --1.33M |
| Operating profit | -2,465.60%-6.67M | -162.97%-2.92M | 34.99%-2.39M | 82.18%-2.7M | 85.88%-578K | 110.58%282K | 335.84%4.64M | -85.36%-3.67M | -330.00%-15.17M | 26.27%-4.09M |
| Net non-operating interest income (expenses) | -2.63%-39K | 50.63%-39K | 206.98%92K | 17.68%-689K | 19.05%-85K | 38.71%-38K | 24.04%-79K | -14.67%-86K | 7.10%-837K | 74.94%-105K |
| Non-operating interest income | -32.58%89K | -1.01%98K | 136.63%239K | -18.16%401K | -48.89%69K | 2.33%132K | 4.21%99K | -23.48%101K | --490K | --135K |
| Non-operating interest expense | -24.71%128K | -23.03%137K | -21.39%147K | -17.68%689K | -35.83%154K | -10.99%170K | -10.55%178K | -9.66%187K | -7.10%837K | 14.29%240K |
| Net investment income | 3.36%2.98M | 9.63%3.28M | -17.96%2.95M | 0.25%12.8M | 4.55%3.33M | -7.11%2.89M | -8.53%2.99M | 12.07%3.59M | 12.77M | 3.19M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 105K | -53.42%272K | 0 | 0 | 0 | 54.91%584K | 1,834.93%6.48M | |||
| Less:Other special charges | ---105K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.55M | ---6.48M |
| Less:Write off | ---- | ---- | ---- | 53.42%-272K | ---- | ---- | ---- | ---- | -54.91%-584K | ---- |
| Other non-operating income (expenses) | 201.11%71.3M | 55M | 84.99%23.68M | |||||||
| Income before tax | -215.65%-3.62M | -95.79%318K | 492.77%652K | 725.38%68.19M | 954.10%57.67M | 652.64%3.13M | 516.33%7.55M | -114.45%-166K | -5.59%8.26M | 223.15%5.47M |
| Income tax | -100.79%-5K | 771.43%549K | 1,151.85%338K | 78.73%1.38M | 2,035.29%658K | 75.00%630K | -85.48%63K | 145.45%27K | -58.68%771K | -102.61%-34K |
| Net income | -244.58%-3.62M | -103.09%-231K | 262.69%314K | 791.95%66.81M | 935.64%57.01M | 4,366.07%2.5M | 846.52%7.49M | -116.96%-193K | 8.80%7.49M | 1,318.81%5.51M |
| Net income continuous operations | -244.58%-3.62M | -103.09%-231K | 262.69%314K | 791.95%66.81M | 935.64%57.01M | 4,366.07%2.5M | 846.52%7.49M | -116.96%-193K | 8.80%7.49M | 1,318.81%5.51M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | -244.58%-3.62M | -103.09%-231K | 262.69%314K | 791.95%66.81M | 935.64%57.01M | 4,366.07%2.5M | 846.52%7.49M | -116.96%-193K | 8.22%7.49M | 1,318.81%5.51M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -244.58%-3.62M | -103.09%-231K | 262.69%314K | 791.95%66.81M | 935.64%57.01M | 4,366.07%2.5M | 846.52%7.49M | -116.96%-193K | 8.22%7.49M | 1,318.81%5.51M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -242.86%-0.005 | -102.91%-0.0003 | 233.33%0.0004 | 795.15%0.0922 | 935.53%0.0787 | 3,400.00%0.0035 | 836.36%0.0103 | -100.19%-0.0003 | 8.42%0.0103 | 1,420.00%0.0076 |
| Diluted earnings per share | -242.86%-0.005 | -102.91%-0.0003 | 233.33%0.0004 | 795.15%0.0922 | 935.53%0.0787 | 3,400.00%0.0035 | 836.36%0.0103 | -100.19%-0.0003 | 8.42%0.0103 | 1,420.00%0.0076 |
| Dividend per share | 0 | 0.00%0.01 | 0 | 0.00%0.01 | 0 | 0 | 0.00%0.01 | 0 | 0.01 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.